Founders Fund V Management is an investment fund managing more than $1.16 billion ran by Neil Pai. There are currently 3 companies in Mr. Pai’s portfolio. The largest investments include Applied Molecular Trans Inc and Unity Biotechnology Inc, together worth $1.06 billion.
As of 7th August 2023, Founders Fund V Management’s top holding is 3,611,615 shares of Applied Molecular Trans Inc currently worth over $932 million and making up 80.2% of the portfolio value.
In addition, the fund holds 49,172 shares of Unity Biotechnology Inc worth $125 million, whose value fell 33.5% in the past six months.
The third-largest holding is Rigetti Computing Inc worth $104 million.
Currently, Founders Fund V Management's portfolio is worth at least $1.16 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Founders Fund V Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Neil Pai serves as the General Counsel at Founders Fund V Management.
In the most recent 13F filing, Founders Fund V Management revealed that it had opened a new position in
Unity Biotechnology Inc and bought 49,172 shares worth $125 million.
On the other hand, there are companies that Founders Fund V Management is getting rid of from its portfolio.
Founders Fund V Management closed its position in Leafly Holdings Inc on 14th August 2023.
It sold the previously owned 354,339 shares for $1.59 million.
The two most similar investment funds to Founders Fund V Management are Doyle Wealth Management and Neville Rodie & Shaw Inc. They manage $1.16 billion and $1.16 billion respectively.
Founders Fund V Management’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 10.8% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
33% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $39.6 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Applied Molecular Trans Inc |
No change
3,611,615
|
$931,797,000 | 80.24% |
| Unity Biotechnology Inc |
Opened
49,172
|
$125,389,000 | 10.80% |
| Rigetti Computing Inc |
Opened
88,621
|
$104,130,000 | 8.97% |
| Leafly Holdings Inc |
Closed
354,339
|
$1,594,000 | |
| Unity Biotechnology Inc |
Closed
491,751
|
$275,000 | |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||